CHS Inc. (CHSCN) Stock Competitors & Peer Comparison
See (CHSCN) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCN | $25.05 | -0.36% | 307.4M | N/A | N/A | +7.28% |
| ADM | $80.12 | -0.12% | 38.6B | 35.75 | $2.24 | +2.58% |
| BG | $126.68 | +0.94% | 24.6B | 33.34 | $3.80 | +2.26% |
| TSN | $56.47 | -0.91% | 20.1B | 44.45 | $1.27 | +3.61% |
| SFD | $26.67 | +1.60% | 10.5B | 10.38 | $2.57 | +4.22% |
| AGRO | $11.29 | -0.96% | 6.4B | 564.50 | $0.02 | +2.66% |
| CALM | $77.69 | +1.77% | 3.7B | 5.41 | $14.37 | +6.22% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | +1.84% |
| FDP | $28.56 | +1.13% | 1.4B | 19.67 | $1.45 | +4.22% |
| DOLE | $13.98 | +2.12% | 1.3B | 15.02 | $0.93 | +2.46% |
Stock Comparison
CHSCN vs ADM Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, ADM has a market cap of 38.6B. Regarding current trading prices, CHSCN is priced at $25.05, while ADM trades at $80.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 35.75. In terms of profitability, CHSCN's ROE is +0.05%, compared to ADM's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ADM's competition here
CHSCN vs BG Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, BG has a market cap of 24.6B. Regarding current trading prices, CHSCN is priced at $25.05, while BG trades at $126.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas BG's P/E ratio is 33.34. In terms of profitability, CHSCN's ROE is +0.05%, compared to BG's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check BG's competition here
CHSCN vs TSN Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, TSN has a market cap of 20.1B. Regarding current trading prices, CHSCN is priced at $25.05, while TSN trades at $56.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 44.45. In terms of profitability, CHSCN's ROE is +0.05%, compared to TSN's ROE of +0.02%. Regarding short-term risk, CHSCN is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSN's competition here
CHSCN vs SFD Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, SFD has a market cap of 10.5B. Regarding current trading prices, CHSCN is priced at $25.05, while SFD trades at $26.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SFD's P/E ratio is 10.38. In terms of profitability, CHSCN's ROE is +0.05%, compared to SFD's ROE of +0.15%. Regarding short-term risk, CHSCN is less volatile compared to SFD. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SFD's competition here
CHSCN vs AGRO Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AGRO has a market cap of 6.4B. Regarding current trading prices, CHSCN is priced at $25.05, while AGRO trades at $11.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is 564.50. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRO's ROE of +0.01%. Regarding short-term risk, CHSCN is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRO's competition here
CHSCN vs CALM Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, CALM has a market cap of 3.7B. Regarding current trading prices, CHSCN is priced at $25.05, while CALM trades at $77.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 5.41. In terms of profitability, CHSCN's ROE is +0.05%, compared to CALM's ROE of +0.26%. Regarding short-term risk, CHSCN is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CALM's competition here
CHSCN vs IBA Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCN is priced at $25.05, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCN's ROE is +0.05%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCN is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check IBA's competition here
CHSCN vs FDP Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, FDP has a market cap of 1.4B. Regarding current trading prices, CHSCN is priced at $25.05, while FDP trades at $28.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 19.67. In terms of profitability, CHSCN's ROE is +0.05%, compared to FDP's ROE of +0.03%. Regarding short-term risk, CHSCN is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check FDP's competition here
CHSCN vs DOLE Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, DOLE has a market cap of 1.3B. Regarding current trading prices, CHSCN is priced at $25.05, while DOLE trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 15.02. In terms of profitability, CHSCN's ROE is +0.05%, compared to DOLE's ROE of +0.03%. Regarding short-term risk, CHSCN is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DOLE's competition here
CHSCN vs VITL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, VITL has a market cap of 449.1M. Regarding current trading prices, CHSCN is priced at $25.05, while VITL trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 10.08. In terms of profitability, CHSCN's ROE is +0.05%, compared to VITL's ROE of +0.14%. Regarding short-term risk, CHSCN is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VITL's competition here
CHSCN vs LND Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, LND has a market cap of 367.6M. Regarding current trading prices, CHSCN is priced at $25.05, while LND trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LND's P/E ratio is -123.00. In terms of profitability, CHSCN's ROE is +0.05%, compared to LND's ROE of -0.02%. Regarding short-term risk, CHSCN is less volatile compared to LND. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LND's competition here
CHSCN vs CHSCP Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, CHSCP has a market cap of 340.1M. Regarding current trading prices, CHSCN is priced at $25.05, while CHSCP trades at $27.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCP's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCP's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to CHSCP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCP's competition here
CHSCN vs CHSCO Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, CHSCO has a market cap of 321M. Regarding current trading prices, CHSCN is priced at $25.05, while CHSCO trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCO's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCO. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCO's competition here
CHSCN vs CHSCL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, CHSCL has a market cap of 315.9M. Regarding current trading prices, CHSCN is priced at $25.05, while CHSCL trades at $25.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCL's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCL. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCL's competition here
CHSCN vs CHSCM Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, CHSCM has a market cap of 306.1M. Regarding current trading prices, CHSCN is priced at $25.05, while CHSCM trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCM's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCM. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCM's competition here
CHSCN vs ALCO Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, ALCO has a market cap of 305.3M. Regarding current trading prices, CHSCN is priced at $25.05, while ALCO trades at $41.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -16.73. In terms of profitability, CHSCN's ROE is +0.05%, compared to ALCO's ROE of -0.18%. Regarding short-term risk, CHSCN is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ALCO's competition here
CHSCN vs AFRI Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AFRI has a market cap of 267.8M. Regarding current trading prices, CHSCN is priced at $25.05, while AFRI trades at $9.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -22.07. In terms of profitability, CHSCN's ROE is +0.05%, compared to AFRI's ROE of +2.87%. Regarding short-term risk, CHSCN is less volatile compared to AFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AFRI's competition here
CHSCN vs VFF Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, VFF has a market cap of 238.9M. Regarding current trading prices, CHSCN is priced at $25.05, while VFF trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VFF's P/E ratio is 9.50. In terms of profitability, CHSCN's ROE is +0.05%, compared to VFF's ROE of +0.14%. Regarding short-term risk, CHSCN is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VFF's competition here
CHSCN vs LMNR Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, LMNR has a market cap of 219.1M. Regarding current trading prices, CHSCN is priced at $25.05, while LMNR trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -9.45. In terms of profitability, CHSCN's ROE is +0.05%, compared to LMNR's ROE of -0.13%. Regarding short-term risk, CHSCN is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LMNR's competition here
CHSCN vs AGFS Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCN is priced at $25.05, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCN is more volatile compared to AGFS. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AGFS's competition here
CHSCN vs LOCL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, LOCL has a market cap of 30.3M. Regarding current trading prices, CHSCN is priced at $25.05, while LOCL trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.73. In terms of profitability, CHSCN's ROE is +0.05%, compared to LOCL's ROE of +0.44%. Regarding short-term risk, CHSCN is less volatile compared to LOCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL's competition here
CHSCN vs PME Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCN is priced at $25.05, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCN's ROE is +0.05%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCN is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check PME's competition here
CHSCN vs AFRIW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AFRIW has a market cap of 17.6M. Regarding current trading prices, CHSCN is priced at $25.05, while AFRIW trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRIW's P/E ratio is -28.52. In terms of profitability, CHSCN's ROE is +0.05%, compared to AFRIW's ROE of +2.87%. Regarding short-term risk, CHSCN is more volatile compared to AFRIW. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AFRIW's competition here
CHSCN vs SDOT Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, SDOT has a market cap of 15.4M. Regarding current trading prices, CHSCN is priced at $25.05, while SDOT trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to SDOT's ROE of +6.12%. Regarding short-term risk, CHSCN is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SDOT's competition here
CHSCN vs APPHW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.05, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPHW's competition here
CHSCN vs APPH Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.05, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPH's competition here
CHSCN vs AQB Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AQB has a market cap of 3.7M. Regarding current trading prices, CHSCN is priced at $25.05, while AQB trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -0.97. In terms of profitability, CHSCN's ROE is +0.05%, compared to AQB's ROE of -3.68%. Regarding short-term risk, CHSCN is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AQB's competition here
CHSCN vs EDBLW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, EDBLW has a market cap of 2.9M. Regarding current trading prices, CHSCN is priced at $25.05, while EDBLW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is -0.05. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBLW's ROE of -1.39%. Regarding short-term risk, CHSCN is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBLW's competition here
CHSCN vs KAL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.05, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KAL's competition here
CHSCN vs KALWW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.05, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KALWW's competition here
CHSCN vs AGRI Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AGRI has a market cap of 1.9M. Regarding current trading prices, CHSCN is priced at $25.05, while AGRI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is 0.00. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRI's ROE of -0.92%. Regarding short-term risk, CHSCN is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRI's competition here
CHSCN vs AVX Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AVX has a market cap of 1M. Regarding current trading prices, CHSCN is priced at $25.05, while AVX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AVX's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AVX's ROE of -0.87%. Regarding short-term risk, CHSCN is less volatile compared to AVX. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AVX's competition here
CHSCN vs AGRIW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AGRIW has a market cap of 66.2K. Regarding current trading prices, CHSCN is priced at $25.05, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRIW's ROE of -0.87%. Regarding short-term risk, CHSCN is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRIW's competition here
CHSCN vs EDBL Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, EDBL has a market cap of 63.9K. Regarding current trading prices, CHSCN is priced at $25.05, while EDBL trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBL's ROE of -1.39%. Regarding short-term risk, CHSCN is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBL's competition here
CHSCN vs AAGRW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AAGRW has a market cap of 57.9K. Regarding current trading prices, CHSCN is priced at $25.05, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AAGRW's ROE of +3.27%. Regarding short-term risk, CHSCN is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AAGRW's competition here
CHSCN vs SANW Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, SANW has a market cap of 43.2K. Regarding current trading prices, CHSCN is priced at $25.05, while SANW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SANW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to SANW's ROE of -0.11%. Regarding short-term risk, CHSCN is more volatile compared to SANW. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check SANW's competition here
CHSCN vs AAGR Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, AAGR has a market cap of 5.8K. Regarding current trading prices, CHSCN is priced at $25.05, while AAGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGR's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AAGR's ROE of +3.27%. Regarding short-term risk, CHSCN is more volatile compared to AAGR. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AAGR's competition here
CHSCN vs DTCK Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, DTCK has a market cap of 3.1K. Regarding current trading prices, CHSCN is priced at $25.05, while DTCK trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DTCK's P/E ratio is -0.27. In terms of profitability, CHSCN's ROE is +0.05%, compared to DTCK's ROE of -1.28%. Regarding short-term risk, CHSCN is less volatile compared to DTCK. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DTCK's competition here
CHSCN vs LOCL-WT Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, LOCL-WT has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.05, while LOCL-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL-WT's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to LOCL-WT's ROE of +0.44%. Regarding short-term risk, CHSCN is less volatile compared to LOCL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL-WT's competition here
CHSCN vs TSNU Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, TSNU has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.05, while TSNU trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSNU's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to TSNU's ROE of +0.02%. Regarding short-term risk, CHSCN is less volatile compared to TSNU. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSNU's competition here
CHSCN vs OME Comparison June 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 307.4M. In comparison, OME has a market cap of 0. Regarding current trading prices, CHSCN is priced at $25.05, while OME trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas OME's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to OME's ROE of +0.10%. Regarding short-term risk, CHSCN is more volatile compared to OME. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check OME's competition here